comparemela.com

Latest Breaking News On - Ac immune sa - Page 3 : comparemela.com

AC Immune Reports Full Year 2022 Financial Results and

AC Immune Reports Full Year 2022 Financial Results and Provides Corporate Update Clinical-stage vaccine programs targeting amyloid-beta (Abeta),.

United statesGary waandersChris maggosAndrea pfeiferCorey davisAbeta supraantigenEli lillyHead of investor relations corporate communicationsAlzheimer association international conferenceJanssen pharmaceuticals incBrain communicationsInternational mediaJanssen pharmaceutical companies of johnsonBanner alzheimer instituteCohesion bureauAlzheimer prevention initiative

AC Immune s Alzheimer s Disease Vaccine-candidate

AC Immune’s Alzheimer’s Disease Vaccine-candidate ACI-35.030 Selected for Further Development Data presented at CTAD 2022 confirm excellent clinical.

Andrea pfeiferGenentech rocheEli lillyJanssen pharmaceuticals incJanssen pharmaceutical companies of johnsonJanssen pharmaceuticalsJanssen pharmaceutical companiesClinical trialsLife molecularNasdaq aciuAc immune saAlzheimer 39 sInterim data

AC Immune to Host Key Opinion Leader Webinar on

Webinar to take place on Wednesday, August 24th at 10:00 AM ET / 4:00 PM CETDiscussion to focus on novel therapeutic approaches and the selection of.

United statesBoston universityCynthiaa lemereEli lillyTherapeutic evaluation committeeNational alzheimer associationJanssen pharmaceuticals incBoston university school of medicineHarvard medical schoolBrightfocus foundation scientific review councilScientific advisory councilSelkoe laboratoryRoche groupAnn romney centerNeurologic diseasesEvents page

AC Immune Holds Annual General Meeting of Shareholders

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Gary waandersTom graneySaoyuth nidhAshani lewisEli lillyWerner lanthalerRoy twymanMonica shawAndrea pfeiferDouglas williamsCorey davisAlan colowickJanssen pharmaceuticals incAlzheimer prevention initiativeExchange commissionSwiss federal council

AC Immune Provides Update on Alzheimer s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer s Disease

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Gary waandersAndrea pfeiferFrancisco loperaSaoyuth nidhAshani lewisCorey davisEli lillyAlzheimer association international conferenceBanner alzheimer foundationNational institute onJanssen pharmaceuticals incAlzheimer prevention initiativeExchange commissionUniversity of antioquiaSecurities exchangeRoche group

vimarsana © 2020. All Rights Reserved.